2,5-Bis(1,1,3,3-tetramethylbutyl)hydroquinone, 95%, 1g

Gilteritinib, 95%, 1g

N-(3-(DIFLUOROMETHYL)PHENYL)-N,O-DIMETHYLHYDROXYLAMINE, 95.0%, 5g

3,3,3-Trifluoropropyl 2-methoxyphenyl sulfide, 99.0%, 5g

2-Pyridyl Trifluoromethanesulfonate>98.0%(GC)5g

1-(diazyn-1-ium-1-yl)-4,7,10,13-tetraoxa-1-azatetradecan-1-ide, >98.0%(HPLC), 1g

(R,S)-Boc-3-amino-2-(naphthalen-1-ylmethyl)-propionic acid, 97.0%, 250mg

K-Oxyma, PEPTIPURE®, min. 99%, 250 g, glass packaging

2-(2,5-dimethyl-1H-pyrrol-1-yl)ethanol, 95.0%, 250mg

1-[2-(Triisopropylsilyl)ethynyl]-3,3-bis(trifluoromethyl)-1,2-benziodoxole>98.0%(HPLC)200mg

3-Phenylpropanenitrile, 95.0%, 5g

(E)-1-(4-CHLOROPHENYL)-3-DIMETHYLAMINOPROPENONE, 97.0%, 10g

1-Methyl-1,2,3,4-tetrahydro-quinoline-6-carbaldehyde, 95.0%, 2.5g